Unraveling the Post-Translational Modifications and therapeutical approach in NSCLC pathogenesis

Non-Small Cell Lung Cancer (NSCLC) is the most prevalent kind of lung cancer with around 85% of total lung cancer cases. Despite vast therapies being available, the survival rate is low (5 year survival rate is 15%) making it essential to comprehend the mechanism for NSCLC cell survival and progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulhane, Pooja, Singh, Shailza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133877/
https://www.ncbi.nlm.nih.gov/pubmed/37062237
http://dx.doi.org/10.1016/j.tranon.2023.101673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133877/
https://www.ncbi.nlm.nih.gov/pubmed/37062237
http://dx.doi.org/10.1016/j.tranon.2023.101673

Ejemplares similares